Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Brain Neoplasms 9 Sarcoma 7 Glioma 6 Meningioma 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Pancreatic Neoplasms 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Rhabdomyosarcoma 3 Radiation Injuries 3 Glioblastoma 3 Chondrosarcoma 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Pituitary Neoplasms 2 Pinealoma 2 Osteosarcoma 2 Oligodendroglioma 2 Nerve Sheath Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Ependymoma 2 Craniopharyngioma 2 Chordoma 2 Cholangiocarcinoma 2

Interventions

Cisplatin 28 Pemetrexed 24 pembrolizumab 12 Nivolumab 10 Carboplatin 9 atezolizumab 7 Gemcitabine 7 Cyclophosphamide 7 durvalumab 6 Drug Therapy 6 sodium thiosulfate 5 Radiotherapy, Intensity-Modulated 5 tremelimumab 4 aldesleukin 4 Radiotherapy 4 Interleukin-2 4 sargramostim 3 Vinorelbine 3 Platinum 3 Photochemotherapy 3 Ipilimumab 3 Doxorubicin 3 Dihematoporphyrin Ether 3 Chemotherapy, Adjuvant 3 Cerebral Decortication 3 vatalanib 2 regorafenib 2 niraparib 2 lenvatinib 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma, Malignant × Proton Therapy × Clear all

NCT05655078 2026-03-30

HIT-Meso

University College, London

Phase NA Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡